Salt-induced hemodynamic regulation mediated by nitric oxide

Journal of Hypertension

Volumn 29, Issue 3, 2011, Pages 415-424

  Toda, Noboru ^a   Arakawa, Kikuo ^b  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

endothelial dysfunction; hypertension; nitric oxide; nitric oxide synthase isoform; oxidative stress; salt; salt sensitivity

Indexed keywords

ANGIOTENSIN II; ASCORBIC ACID; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MIBEFRADIL; N(G),N(G) DIMETHYLARGININE; NEBIVOLOL; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OLMESARTAN; PRAVASTATIN; SEMAXANIB; VASCULOTROPIN;

BLOOD FLOW; BLOOD LEVEL; BLOOD PRESSURE; DAHL SALT SENSITIVE RAT; DRUG MECHANISM; ENZYME ACTIVATION; HEMODYNAMICS; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SALT INTAKE;

EID: 79951672610     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328341d19e     Document Type: Review

References (74)

1. Oberleithner H, Kusche-Vihorg K, Schillers H. Endothelial cells as vascular salt sensors. Kidney Int 2010; 77:490-494.
2. Raij L. Nitric oxide, salt sensitivity, and cardiorenal injury in hypertension. Semin Nephrol 1999; 19:296-303. (Pubitemid 29200838)
3. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev 2009; 61:62-97.
4. Toda N, Okamura T. Modulation of renal blood flow and vascular tone by neuronal nitric oxide synthase-derived nitric oxide. J Vasc Res 2010; 48: 1-10.
5. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362:650-652.
6. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature (Lond) 1990; 347:768-770.
7. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (Lond) 1999; 399:601-605.
8. Toda N, Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 2003; 55:271-324. (Pubitemid 36666049)
9. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339:572-575.
10. Garthwaite J, Southam E, Boulton CL, Nedlsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo]4,3-a]quinoxalin-1-one. Mol Pharmacol 1995; 48:184-188.
11. Facchini FS, DoNascimento C, Reaven GM, Yip JW, Ni XP, Humphreys MH. Blood pressure, sodium intake, insulin resistance, and urinary nitrate excretion. Hypertension 1999; 33:1008-1012. (Pubitemid 29186400)
12. Cubeddu LX, Alfieri AB, Hoffmann IS, Jimenez E, Roa CM, Cubeddu R, Palermo C. Nitric oxide and salt sensitivity. Am J Hypertens 2000; 13:973-979.
13. Hoffmann IS, Alfieri AB, Cubeddu LX. Effects of lifestyle changes and metformin on salt sensitivity and nitric oxide metabolism in obese salt-sensitive Hispanics. J Hum Hypertens 2007; 21:571-578. (Pubitemid 47018632)
14. Scuteri A, Stuehlinger MC, Cooke JP, Wright JG, Lakatta EG, Anderson DE, Fleg JL. Nitric oxide inhibition as a mechanism for blood pressure increase during salt loading in normotensive postmenopausal women. J Hypertens 2003; 21:1339-1346.
15. Henandez-Schulman I, Raij L. Salt sensitivity and hypertension after menopause: role of nitric oxide and angiotensin II. Am J Nephrol 2006; 26:170-180. (Pubitemid 43882402)
16. Barba G, Vallance PJ, Strazzullo P, MacAllister RJ. Effects of sodium intake on the pressor and renal responses to nitric oxide synthesis inhibition in normotensive individuals with different sodium sensitivity. J Hypertens 2000; 18:615-621. (Pubitemid 30303493)
17. Campese VM, Amar M, Anjali C, Medhat T, Wurgaft A. Effect of L-arginine on systemic and renal haemodynamics in salt-sensitive patients with essential hypertension. J Hum Hypertens 1997; 11:527-532. (Pubitemid 27434782)
18. Fujiwara N, Osanai T, Kamada T, Katoh T, Takahashi K, Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation 2000; 101:856-861. (Pubitemid 30117880)
19. Osanai T, Fujiwara N, Saitoh M, Sasaki S, Tomita H, Nakamura M, et al. Relationship between salt intake, nitric oxide and asymmetric dimethylarginine and its relevance to patients with end-stage renal disease. Blood Pufi 2002; 20:466-468. (Pubitemid 35007563)
20. Bragulat E, de la Sierra A. Salt intake, endothelial dysfunction, and salt-sensitive hypertension. J Clin Hypertens 2002; 4:41-46. (Pubitemid 34163045)
21. Bragulat E, de la Sierra A, Antonio MT, Coca A. Endothelial dysfunction in salt-sensitive essential hypertension. Hypertension 2001; 37:444-448. (Pubitemid 32199009)
22. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Noma K, Sasaki S, et al. Sodium chloride loading does not alter endothelium-dependent vasodilation of forearm vasculature in either salt-sensitive or salt-resistant patients with essential hypertension. Hypertens Res 2001; 24:711-716. (Pubitemid 33133786)
23. Miyaki K, Tohyama S, Murata M, Kikuchi H, Takei I, Watanabe K, et al. Salt intake affects the relation between hypertension and the T-786C polymorphism in the endothelial nitric oxide synthase gene. Am J Hypertens 2005; 18:1556-1562. (Pubitemid 41814676)
24. Campese VM, Tawadrous M, Bigazzi S, Bianchi S,Mann AS, Oparil S, et al. Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. Hypertension 1996; 28:335-340. (Pubitemid 26296031)
25. Hoffmann IS, Tavares-Mordwinkin R, Castejon AM, Cubeddu LX. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 2005; 19:233-240. (Pubitemid 40360940)
26. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol 2003; 284:R1-R12. (Pubitemid 36008649)
27. Oberleithner H, Riethmüller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA 2007; 104:16281-16286. (Pubitemid 350099397)
28. Toilns JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 1994; 46:230-236. (Pubitemid 24210456)
29. Ni Z, Vaziri ND. Effect of salt loading on nitric oxide synthase expression in normotensive rats. Am J Hypertens 2001; 14:155-163. (Pubitemid 32171568)
30. Tojo A, Kimoto M, Wilcox CS. Renal expression of constitutive NOS and DDAH: separate effects of salt intake and angiotensin. Kidney Int 2000; 58:2075-2083.
31. Sofola O, Knill A, Myers D, Hainsworth R, Drinkhill M. High-salt diet and responses of the pressurized mesenteric artery of the dog to noradrenaline and acetylcholine. Clin Exp Pharmacol Physiol 2004; 31:696-699. (Pubitemid 39540319)
32. Hodge G, Ye VZ, Duggan KA. Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat. Exp Physiol 2002; 87:1-8. (Pubitemid 34083241)
33. Kopkan L, Cervenka L. Renal interactions of renin-angiotensin system, nitric oxide and superoxide anion: implications in the pathophysiology of salt-sensitivity and hypertension. Physiol Res 2009; 58 (Suppl 2):S55-S67.
34. Song WZ, Chen AF, Wang DH. Increased salt sensitivity induced by sensory denervation: role of superoxide. Acta Pharmacol Sin 2004; 25:1626-1632. (Pubitemid 39628030)
35. Kopkan L, Majid DS. Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency. Hypertension 2005; 46:1026-1031.
36. Carlström M, Brown RD, Sä llström J, Larsson E, Zilmer M, Zabihi S, et al. SOD1 deficiency causes salt sensitivity and aggravates hypertension in hydronephrosis. Am J Physiol 2009; 297:R82-R92.
37. Hirai T, Okumura K, Nishimoto Y, Shumiya T, Murakami R, Takahashi R, et al. Upregulation of renal eNOS by high-sodium diet facilitates hypertension in doxorubicin-treated rat through enhanced oxidative stress. Toxicology 2006; 225:81-89. (Pubitemid 44108368)
38. Banday AA, Muhammad AB, Fazili FR, Lokhandwala M. Mechanisms of oxidative stress-induced increase in salt sensitivity and development of hypertension in Sprague-Dawley rats. Hypertension 2007; 49:664-671.
39. Alvarez G, Osuna A, Wangensteen R, Vargas F. Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure. Hypertension 2000; 35:752-757. (Pubitemid 30165321)
40. Sasser JM, Sullivan JC, Elmarakby AA, Kemp BE, Pollock DM, Pollock JS. Reduced NOS3 phosphorylation mediates reduced NO/cGMP signaling in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2004; 43:1080-1085. (Pubitemid 38579917)
41. Li J, White J, Guo L, Zhao X, Wang J, Smart EJ, et al. Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr 2009; 139:447-451.
42. Manning RD Jr, Meng S, Tian N. Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 2003; 179:243-250. (Pubitemid 37464109)
43. Ghosh M, Wang JD, McNeill JR. Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats. Br J Pharmacol 2004; 141:562-573. (Pubitemid 38453248)
44. Tojo A, Onozato ML, Kobayashi N, Goto A, Matsuoka H, Fujita T. Angiotensin II and oxidative stress in Dahl salt-sensitive rat with heart failure. Hypertension 2002; 40:834-839. (Pubitemid 35434903)
45. Zhou MS, Adam AG, Jaimes EA, Raij L. In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension 2003; 42:945-951. (Pubitemid 37413735)
46. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD Jr. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 2005; 45:934-939. (Pubitemid 40628940)
47. Zhou MS, Schulman IH, Raij L. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor-kB activation. J Hypertens 2010; 28:527-535.
48. Wood PA, Hamm DA, Chen PY, Sanders PW. Studies of arginine metabolism and salt sensitivity in the Dahl/Rapp rat models of hypertension. Mol Genet Metab 1998; 64:80-83. (Pubitemid 28453323)
49. Gu JW, Manning RD Jr, Young E, Shparago M, Sartin B, Bailey AP. Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats. Am J Physiol 2009; 297:R142-R148.
50. Leonard AM, Chafe LL, Montani JP, Van Vliet BN. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice. Am J Hypertens 2006; 19:1264-1269. (Pubitemid 44856255)
51. Daumerie G, Bridges L, Yancey S, Davis W, Huang P, Loscalzo J, et al. The effect of salt on renal damage in eNOS-deficient mice. Hypertens Res 2010; 33:170-176.
52. Mattson DL, Meister CJ. Sodium sensitivity of arterial blood pressure in L-NAME hypertensive but not eNOS knockout mice. Am J Hypertens 2006; 19:327-329. (Pubitemid 43261517)
53. Chlopicki S, Kozlovski VI, Lokowska B, Drelicharz L, Gebska A. Compensation of endothelium-dependent responses in coronary circulation of eNOS-deficient mice. J Cardiovasc Pharmacol 2005; 46:115-123. (Pubitemid 40917787)
54. Gödecke A, Schrader J. Adaptive mechanisms of the cardiovascular system in transgenic mice: lesions from eNOS and myoglobin knockout mice. Basic Res Cardiol 2000; 95:492-498. (Pubitemid 32013990)
55. Heintz A, Damm M, Brand M, Koch T, Deussen A. Coronary flow regulation in mouse heart during hypercapnic acidosis: role of NO and its compensation during eNOS impairment. Cardiovasc Res 2008; 77:188-196. (Pubitemid 351195144)
56. Toda N, Ayajiki K, Okamura T. Control of systemic and pulmonary blood pressure by nitric oxide formed through neuronal nitric oxide synthase. J Hypertens 2009; 27:1929-1940.
57. Tan DY, Meng S, Manning RD Jr. Role of neuronal nitric oxide synthesis in Dahl salt-sensitive hypertension. Hypertension 1999; 33:456-461. (Pubitemid 29065702)
58. Manning RD Jr, Hu L, Tan DY, Meng S. Role of abnormal nitric oxide systems in salt-sensitive hypertension. Am J Hypertens 2001; 14:68S- 73S.
59. Persson AE, Gutierrez A, Pittner J, Ring A, Ollerstam A, Brown R, et al. Renal NO production and the development of hypertension. Acta Physiol Scand 2000; 168:169-174. (Pubitemid 30128684)
60. Yoshihara F, Suga S, Yasui N, Horio T, Tokudome T, Nishikimi T, et al. Chronic administration of adrenomedullin attenuates the hypertension and increases renal nitric oxide synthase in Dahl salt-sensitive rats. Regul Pept 2005; 128:7-13. (Pubitemid 40255529)
61. Obst M, Gross V, Bonartsev A, Janke J, Mü ller DN, Park JK, et al. Nitric oxide synthase expression in AT2 receptor-deficient mice after DOCA-salt. Kidney Int 2004; 65:2268-2278. (Pubitemid 38670013)
62. Roberts CK, Vaziri ND, Sindhu RK, Barnard RJ. A high-fat, refined-carbohydrate diet affects renal NO synthase protein expression and salt sensitivity. J Appl Physiol 2003; 94:941-946. (Pubitemid 36232007)
63. Campese VM, Mozayeni P, Ye S,Gumbard M. High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure. J Nephrol 2002; 15:407-413.
64. Rudd MA, Trolliet M, Hope S, Scribner AW, Daumerie G, Toolan G, et al. Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOS II inhibition. Am J Physiol 1999; 277:H732-H739. (Pubitemid 29415988)
65. Tan DY, Meng S, Cason GW, Manning RD Jr. Mechanisms of salt-sensitive hypertension: role of inducible nitric oxide synthase. Am J Physiol 2000; 279:R2297-R2303.
66. Nadaud S, Mao C, Luvàra G, Michel JB, Soubrier F. Isoform-specific regulation of nitric oxide synthase mRNA in the kidney by sodium and blood pressure. J Hypertens 1998; 16:1315-1323. (Pubitemid 28408415)
67. \+ channel inhibitor RO40-5967 potentiates endothelium-dependent relaxations in the aorta of the hypertensive salt sensitive Dahl rat. Blood Press 1994; 3:193-196. (Pubitemid 24169152)
68. Krenek P, Salomone S, Kyselovic J, Wibo M, Morel N, Goodfraind T. Lacidipine presents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats. Hypertension 2001; 37:1124-1128. (Pubitemid 32304014)
69. Cosentino F, Bonetti S, Rehorik R, Eto M, Werner-Felmayer G, Volpe M, et al. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic b1-selective receptor blockade. J Hypertens 2002; 20:421-428. (Pubitemid 34913741)
70. Toda N. Vasodilating b-adrenoceptor blockers as cardiovascular therapeutics. Pharmacol Ther 2003; 100:215-234. (Pubitemid 37494907)
71. Ettarh RR, Odigie IP, Adigun SA. Vitamin C lowers blood pressure and alters vascular responsiveness in salt-induced hypertension. Can J Physiol Pharmacol 2002; 80:1199-1202. (Pubitemid 36249902)
72. Yamamoto E, Yamashita T, Tanaka T, Kataoka K, Tokutomi Y, Lai ZF, et al. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects. Arterioscler Thromb Vasc Biol 2007; 27:556-563.
73. Satoh M,Harna Y, Fujimoto S, Sasaki T, Kashihara N. Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats. Hypertens Res 2010; 33:135-142.
74. Sartori-Valinotti JC, Venegas-Pont MR, Lamarca BB, Romero DG, Yanes LL, Racusen LC, et al. Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats. Steroids 2009; 75:794-799.